Comment from Kandice Norrell
AnonymousOpposeIndividual
Summary: A veterinary professional (implied by the mention of "feline practice" and "patients") argues that the new FDA regulations for in-stock medications will delay critical treatments for animals. They specifically highlight that the delay in accessing medications like metronidazole could be life-threatening for kittens with severe diarrhea.
The new FDA regulations for in stock medications is making feline practice difficult and delaying critical therapy for feline patients. In the case of metronidazole, patients with Giardia or other antibiotic responsive diarrhea will now have a considerable delay in therapy. In some cases, severe diarrhea in kittens can be life threatening. The FDA regulations may result in loss of lives by overstepping boundaries in allow quick access to critical therapy for our patients.